Who is sponsoring NCT04195620?

NCT04195620 is sponsored by Morehead State University.

What drugs are being tested in NCT04195620?

Interventions in NCT04195620: High self-disclosure, Low self-disclosure.

What condition does NCT04195620 study?

NCT04195620 studies Cardiovascular Diseases.

Is NCT04195620 still recruiting?

NCT04195620 is currently terminated. Last updated 29 April 2022.

Last reviewed 2022-04-29 · How we verify

NCT04195620

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Loneliness and Social Connection in Cardiovascular Disease

Terminated NA Last updated 29 April 2022

What this trial tests

NA trial testing High self-disclosure in Cardiovascular Diseases in 34 participants. Terminated before completion.

Timeline

1 September 2020

Primary endpoint
1 January 2022

1 January 2022

Quick facts

Lead sponsor	Morehead State University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	other
Enrollment	34
Start date	1 September 2020
Primary completion	1 January 2022
Estimated completion	1 January 2022
Sites	1 location across United States

Drugs / interventions tested

High self-disclosure
Low self-disclosure

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Morehead State University

Who can join

Adults 18 to 25, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluates the impact of vulnerable self-disclosure and perceived responsiveness in individuals across levels of loneliness. Participants will be randomized to a high disclosure or a low disclosure condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04195620 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Morehead State University
Last refreshed: 29 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04195620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing